Henan Taloph Pharmaceutical Stock Co.,Ltd. Posted 19.5 Million Yuan Net Loss in First Three Quarters of 2023

Henan Taloph Pharmaceutical Stock Co.,Ltd. (河南太龙药业股份有限公司) (600222.SH) reported a net loss of 19.5 million yuan in the first three quarters of 2023, narrowing 66.5% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, up 11.2% year-on-year.

At the end of the reporting period, it had 3.3 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 55.3%.